XML 30 R16.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Investments in and Advances to Nonconsolidated Affiliates | 12 Months Ended
--- | ---
Dec. 31, 2018
Investments in and Advances to Affiliates, Schedule of Investments [Abstract] |
Investments in and Advances to Nonconsolidated Affiliates | Investments in and Advances to Nonconsolidated Affiliates: Investments in and advances to nonconsolidated affiliates as of December 31, 2018 represents our investment in five partially owned subsidiaries, of which four are general or limited partnerships, limited liability companies, or joint ventures in which Encompass Health or one of its subsidiaries is a general or limited partner, managing member, member, or venturer, as applicable. We do not control these affiliates but have the ability to exercise significant influence over the operating and financial policies of certain of these affiliates. Our ownership percentages in these affiliates range from approximately 19% to 60%. We account for these investments using the cost and equity methods of accounting. Our investments, which are included in Other long-term assets in our consolidated balance sheets, consist of the following (in millions):
| As of December 31,
| 2018 |  | 2017
Equity method investments: |  |  |
Capital contributions | $ | 0.9 |  |  | $ | 0.9 |
Cumulative share of income | 114.0 |  |  | 105.3 |
Cumulative share of distributions | (102.7 | ) |  | (94.5 | )
| 12.2 |  |  | 11.7 |
Cost method investments: |  |  |  |  |
Capital contributions, net of distributions and impairments | — |  |  | 0.2 |
Total investments in and advances to nonconsolidated affiliates | $ | 12.2 |  |  | $ | 11.9 |
The following summarizes the combined assets, liabilities, and equity and the combined results of operations of our equity method affiliates (on a 100% basis, in millions):
| As of December 31,
| 2018 |  | 2017
Assets— |  |  |
Current | $ | 9.9 |  |  | $ | 10.1 |
Noncurrent | 17.8 |  |  | 18.3 |
Total assets | $ | 27.7 |  |  | $ | 28.4 |
Liabilities and equity— |  |  |  |  |
Current liabilities | $ | 1.4 |  |  | $ | 2.7 |
Noncurrent liabilities | 0.1 |  |  | 0.2 |
Partners’ capital and shareholders’ equity— |  |  |  |  |
Encompass Health | 12.2 |  |  | 11.7 |
Outside partners | 14.0 |  |  | 13.8 |
Total liabilities and equity | $ | 27.7 |  |  | $ | 28.4 |
Condensed statements of operations (in millions):
| For the Year Ended December 31,
| 2018 |  | 2017 |  | 2016
Net operating revenues | $ | 42.6 |  |  | $ | 40.9 |  |  | $ | 44.8 |
Operating expenses | (25.6 | ) |  | (24.1 | ) |  | (24.3 | )
Income from continuing operations, net of tax | 17.1 |  |  | 17.0 |  |  | 20.5 |
Net income | 17.1 |  |  | 17.0 |  |  | 20.5 |

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates. It reflects specified information about ownership, financial results from, and financial position in such entities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2324412 + Details
Name: | us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration